Shares of Cardinal Health Inc.

climbed 1.3% into record territory in premarket trading Friday, after the drug distributor reported fiscal first-quarter profit that beat expectations and raised its full-year outlook, while revenue came up a bit shy. Net income for the quarter to Sept. 30 dropped to $5 million, or 2 cents a share, from $110 million, or 40 cents a share, in the year-ago period. Excluding nonrecurring items, such as a $581 million goodwill impairment related to the medical business, adjusted earnings per share rose 44% to $1.73, well above the FactSet consensus of $1.40. Revenue grew 10.4% to $54.76 billion, just below the FactSet consensus of $54.85 billion. Pharmaceutical revenue increased 11.4% to $51.0 billion, but that missed the FactSet consensus of $51.3 billion, while medical revenue was flat at $3.8 billion to match expectations. For fiscal 2024, the company raised its adjusted EPS guidance range to $6.75 to $7.00 from $6.50 to $6.75. The stock has been little changed over the past three months through Thursday, while the S&P 500

has slipped 4.1%.

Source link

Share with your friends!

Products You May Like

Leave a comment

Your email address will not be published. Required fields are marked *

Get the latest stocks updates
straight to your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.